Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 4.37 | 17.18 |
| PEG Ratio (TTM) | -1.17 | 6.12 |
| P/S Ratio (TTM) | 0.48 | 2.87 |
| P/B Ratio (TTM) | 0.78 | -4.82 |
| P/FCF Ratio (TTM) | 1.33 | 22.89 |
| Price to 5YR AVG Earnings Ratio | 96.72 | 34.27 |
| Price to 5YR AVG FCF Ratio | 1.49 | 20.33 |
Profitability (60%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 6.44% | 5.96% |
| ROE (TTM) | 18.30% | -676.88% |
| Net Profit Margin (TTM) | 11.05% | 17.27% |
| ROIC 5YR AVG | 13.20% | 9.02% |
Growth (32%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3.28% | -109.58% | -35.26% |
| Revenue | -2.66% | -18.46% | 8.42% |
| Net Income | 2.73% | -110.64% | -36.90% |
| Cash Flow | -2.25% | 58.30% | 111.01% |
Health (72%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 6.84 | 1.03 |
| Quick Ratio (TTM) | 6.52 | 0.88 |
| D/E Ratio (TTM) | N/A | -2.67 |
| Interest Coverage (TTM) | 35.73 | 3.11 |
| Piotroski F-Score | 9 | 6 |
| Altman Z-Score | 2.84 | 1.65 |
| LTL to 5YR AVG FCF | 0.40 | 6.06 |
| Shares Outstanding Growth 5YR AVG | -1.01% | 8.95% |